Cover Image

Antimicrobial Resistance Determinants in Genomes and Plasmids from <i>Acinetobacter baumannii</i> Clinical Isolates

<i>Acinetobacter baumannii</i> is a Gram-negative coccoid rod species, clinically relevant as a human pathogen, included in the ESKAPE group. Carbapenem-resistant <i>A. baumannii</i> (CRAB) are considered by the World Health Organization (WHO) as a critical priority pathogen...

Full description

Saved in:

Bibliographic Details
Main Authors:	Itziar Chapartegui-González (Author), María Lázaro-Díez (Author), Santiago Redondo-Salvo (Author), Jesús Navas (Author), José Ramos-Vivas (Author)
Format:	Book
Published:	MDPI AG, 2021-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Genetic Resistance Determinants in Clinical <i>Acinetobacter pittii</i> Genomes
by: Itziar Chapartegui-González, et al.
Published: (2022)

Genomic Characterization of Clinical <i>Acinetobacter baumannii</i> Isolates Obtained from COVID-19 Patients in Russia
by: Andrey Shelenkov, et al.
Published: (2022)

DksA Modulates Antimicrobial Susceptibility of <i>Acinetobacter baumannii</i>
by: Nayeong Kim, et al.
Published: (2021)

Biofilm-Induced Antibiotic Resistance in Clinical <i>Acinetobacter baumannii</i> Isolates
by: Abebe Mekuria Shenkutie, et al.
Published: (2020)

Antimicrobial Susceptibility and Characterization of Resistance Mechanisms of <i>Corynebacterium</i> <i>urealyticum</i> Clinical Isolates
by: Itziar Chapartegui-González, et al.
Published: (2020)

Co-Occurrence of <i>bla</i><sub>OXA-23</sub> in the Chromosome and Plasmid: Increased Fitness in Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Zhiren Wang, et al.
Published: (2021)

Isolation and Characterization of Novel Bacteriophages to Target Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Yoon-Jung Choi, et al.
Published: (2024)

Isolation and Characterisation of Bacteriophage Selective for Key <i>Acinetobacter baumannii</i> Capsule Chemotypes
by: Rosesathorn Soontarach, et al.
Published: (2022)

Systematic Review of Antimicrobial Combination Options for Pandrug-Resistant <i>Acinetobacter baumannii</i>
by: Stamatis Karakonstantis, et al.
Published: (2021)

An Update on the Therapeutic Potential of Antimicrobial Peptides against <i>Acinetobacter baumannii</i> Infections
by: Karyne Rangel, et al.
Published: (2023)

CRISPR-Based Gene Editing in <i>Acinetobacter baumannii</i> to Combat Antimicrobial Resistance
by: Muhammad Junaid, et al.
Published: (2023)

Novel Antimicrobial Peptide "Octoprohibitin" against Multidrug Resistant <i>Acinetobacter baumannii</i>
by: E. H. T. Thulshan Jayathilaka, et al.
Published: (2022)

An <i>Acinetobacter</i> non-<i>baumannii</i> Population Study: Antimicrobial Resistance Genes (ARGs)
by: Adam Baraka, et al.
Published: (2020)

Pan-Genome Plasticity and Virulence Factors: A Natural Treasure Trove for <i>Acinetobacter baumannii</i>
by: Theodoros Karampatakis, et al.
Published: (2024)

Prevalence of Carbapenemases in Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates from the Kingdom of Bahrain
by: Nouf Al-Rashed, et al.
Published: (2023)

Dynamic Gene Clusters Mediating Carbapenem-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates
by: Samy Selim, et al.
Published: (2022)

The Antimicrobial Peptide Octopromycin Suppresses Biofilm Formation and Quorum Sensing in <i>Acinetobacter baumannii</i>
by: Dinusha Chathurangi Rajapaksha, et al.
Published: (2023)

Genetic Characterization of Multidrug-Resistant <i>Acinetobacter baumannii</i> and Synergy Assessment of Antimicrobial Combinations
by: Aurora Luna-, et al.
Published: (2024)

Whole-Genome Sequencing of a Colistin-Resistant <i>Acinetobacter baumannii</i> Strain Isolated at a Tertiary Health Facility in Pretoria, South Africa
by: Noel-David Nogbou, et al.
Published: (2022)

Pan-Resistome Insights into the Multidrug Resistance of <i>Acinetobacter baumannii</i>
by: Diego Lucas Neres Rodrigues, et al.
Published: (2021)

Colistin and Carbapenem-Resistant <i>Acinetobacter baumannii</i> Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling
by: Nalumon Thadtapong, et al.
Published: (2021)

Genomic analysis of extensively drug-resistant Acinetobacter baumannii harbouring a conjugative plasmid containing aminoglycoside resistance transposon TnaphA6
by: Satoshi Nishida, et al.
Published: (2024)

Molecular Epidemiology of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates from Northern Africa and the Middle East
by: Paul G. Higgins, et al.
Published: (2021)

In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates
by: Harald Seifert, et al.
Published: (2023)

<i>Acinetobacter baumannii</i> Global Clone-Specific Resistomes Explored in Clinical Isolates Recovered from Egypt
by: Samira M. Hamed, et al.
Published: (2023)

Exploring Roles of the Polysaccharide Capsule in Pathogenesis of Hypervirulent <i>Acinetobacter baumannii</i> Clinical Isolate Lac-4
by: Elisabet Bjånes, et al.
Published: (2023)

Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant <i>Acinetobacter baumannii</i> Patient Isolates
by: Manas S. Deolankar, et al.
Published: (2022)

Antimicrobial Random Peptide Mixtures Eradicate <i>Acinetobacter baumannii</i> Biofilms and Inhibit Mouse Models of Infection
by: Hannah E. Caraway, et al.
Published: (2022)

Antimicrobial Peptide Octoprohibitin-Encapsulated Chitosan Nanoparticles Enhanced Antibacterial Activity against <i>Acinetobacter baumannii</i>
by: E. H. T. Thulshan Jayathilaka, et al.
Published: (2024)

Development of Novel Peptides for the Antimicrobial Combination Therapy against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infection
by: Joonhyeok Choi, et al.
Published: (2021)

Molecular epidemiology and antimicrobial resistance features of Acinetobacter baumannii clinical isolates from Pakistan
by: Nabil Karah, et al.
Published: (2020)

Colistin Resistance in <i>Acinetobacter baumannii:</i> Molecular Mechanisms and Epidemiology
by: Katarina Novović, et al.
Published: (2023)

Treatment Strategies of Colistin Resistance <i>Acinetobacter baumannii</i> Infections
by: Andria Papazachariou, et al.
Published: (2024)

<i>Acinetobacter baumannii</i> Infections in Hospitalized Patients, Treatment Outcomes
by: Diaa Alrahmany, et al.
Published: (2021)

<i>Acinetobacter baumannii</i> Resistance: A Real Challenge for Clinicians
by: Rosalino Vázquez-López, et al.
Published: (2020)

Investigating Bacteriophages Targeting the Opportunistic Pathogen <i>Acinetobacter baumannii</i>
by: Kathryn M. Styles, et al.
Published: (2020)

Prosthetic valve endocarditis caused by <i> Acinetobacter baumannii </i> complex
by: Kumar S, et al.
Published: (2008)

Bacterial Community and Genomic Analysis of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates from the Environment of a Health Care Facility in the Western Region of Saudi Arabia
by: Muhammad Yasir, et al.
Published: (2022)

Characterization of Extremely Drug-Resistant and Hypervirulent <i>Acinetobacter baumannii</i> AB030
by: Manu Singh, et al.
Published: (2020)

In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i>
by: Paraskevi Mantzana, et al.
Published: (2023)